# Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders.

Study · id `cardio:ct-nct05774288` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05774288](<https://clinicaltrials.gov/study/NCT05774288>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05774288

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 244 participants.

## Technical summary

Registry record NCT05774288. Randomized; no masking; primary purpose treatment. Start 2023-06-08 (actual); primary completion 2025-04-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 244 participants (planned count; ClinicalTrials.gov record NCT05774288, source copy `cardio:ctgov-nct05774288-2023-09-01`, retrieved 2026-10-26)
- Started: 2023-06-08 (actual) (ClinicalTrials.gov record NCT05774288, source copy `cardio:ctgov-nct05774288-2023-09-01`, retrieved 2026-10-26)
- Primary completion: 2025-04-30 (anticipated) (ClinicalTrials.gov record NCT05774288, source copy `cardio:ctgov-nct05774288-2023-09-01`, retrieved 2026-10-26)
- Completion: 2029-06-30 (anticipated) (ClinicalTrials.gov record NCT05774288, source copy `cardio:ctgov-nct05774288-2023-09-01`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05774288, source copy `cardio:ctgov-nct05774288-2023-09-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05774288-2023-09-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders.
- Condition: Patent Foramen Ovale
- Condition: Cryptogenic Stroke
- Intervention (Device): Cera™ patent foramen ovale occluders
- Intervention (Device): Another patent foramen ovale occluders
- Lead sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. (`cardio:org-lifetech-scientific-shenzhen-co-ltd`)

## Provenance

Content hash: fa6980279cf28d6bf5c8cc65c3e239e3dea5914a9253fa6c60d2a57c875c6a4b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
